It was found that pathological type (adenocarcinoma) was a risk factor for EGFR mutation in peripheral blood ctDNA (p<0.05), and smoking history was a protective factor for EGFR mutation in peripheral blood ctDNA (p<0.05) (Table-IV). This evidence concerns the gene EGFR and adenocarcinoma.